SMC2 and neuroblastoma: All the CAPE activities seen as above were evident across the cell types and species, as its treatment stimulated differentiation in human (IMR32, GOTO) or rat neuroblastoma (PC12), and rat glioblastoma (C6) cell lines (Figure 3).